Green Bay Packers quarterback Aaron Rodgers is no stranger to controversy. The 18-year veteran has made headlines this offseason for calling out his teammates, admitting to using psychedelics and possibly retiring.
Rodgers made an appearance on the Joe Rogan Experience recently, and the two discussed a wide range of different topics. One of the most jaw-dropping moments of the interview came when Rodgers opened up to Rogan about using Percocets during a game.
Fans were quick to scour through his old matches and post-game interviews to find the match in question. The consensus is that they were successful. A postseason interview emerged where Rodgers seemed a little different to his usual self. He suffered a knee injury and in the first half only completed three passes for 13 yards. In the second half, he completed 17 passes for 273 yards and three touchdowns in an epic comeback.
•
70% Win
(110-25-1)
70% Win
(110-25-1)
70% Win
(110-25-1)
'; }); pollOptions.innerHTML = pollOptionsDom; pollCount.innerHTML = totalVotes + ' votes'; if (totalVotes > 10) { pollCount.classList.remove("hidden"); } } function trackBetsTodayPollImpression() { var intersectionObserverForArticlePoll = new IntersectionObserver( function(entries) { entries.forEach(function(entry) { var pollId = entry.target.getAttribute("data-poll-id"); if (POLLS_BY_ID[pollId]['impression_tracked']) return; if (!entry.target || !entry.isIntersecting || entry.intersectionRatio < 0.5) return; setTimeout(function() { if (isInViewport(entry.target)) { POLLS_BY_ID[pollId]['impression_tracked'] = true; var isDesktop = "1"; var gaPayload = { "question" : POLLS_BY_ID[pollId]['question'], "category": "NFL", "page_url": window.location.href, "option1": POLLS_BY_ID[pollId]['option1'], "option2": POLLS_BY_ID[pollId]['option2'], } if (isDesktop) { gaPayload["device"] = "Desktop"; } else { gaPayload["device"] = "Mobile"; } gtag("event", "BETS_TODAY_POLL_IMPRESSION", gaPayload); intersectionObserverForArticlePoll.unobserve(entry.target); } }, 1000); }); }, { threshold: 0.5 } ); var pollElements = document.querySelectorAll('.bets-today-poll'); pollElements.forEach(function(pollElement) { var isAnswered = pollElement.querySelector(".poll-option-answered"); if (!isAnswered) { intersectionObserverForArticlePoll.observe(pollElement); } }) } return { answerPollX: answerPollX, }; }();Watch the video below and see for yourself:
As the old video made the rounds, fans were quick to share their thoughts on the matter. Here are the top comments:
Also Checkout:- Aaron Rodgers House
Aaron Rodgers is no stranger to drugs
Aaron Rodgers is no stranger to narcotics. While it was news to many that Rodgers took percocets during a game, he opened up about using psychedelics earlier this offseason.
Rodgers spoke about using ayahuasca in South America, stating that it helped him find inner peace. The Green Bay Packers quarterback complimented the narcotic for helping him find himself and repairing past relationships. He spoke on the Aubrey Marcus podcast about how it helped him to love himself and others more effectively.
Rodgers won't face a suspension for his offseason adventures, as he didn't test positive for any banned substances. It's very likely the NFL would rather he keep these matters to himself, but he seems intent on toeing the line.
It will be interesting to see if he manages to talk himself into trouble before too long.
Quick Links
More from Sportskeeda
" modalPopup.closeOnEsc = false; modalPopup.setHeader("Why did you not like this content?"); modalPopup.setContentText(modalText); modalPopup.addCancelOkButton("Submit", resetRatingAndFeedbackForm, sendRating); modalPopup.removeCloseModalIcon(); modalPopup.disableDismissPopup(); modalPopup.open(); } else { sendRating(index); } } function sendRating() { var requestPayload = { "post_id": 1213989, "rating_value": ratingValue } if (ratingValue > 3) { requestPayload.rating_feedback_type = null; requestPayload.rating_feedback = null; } else { if (!$('input[name="drone"]:checked') || !$('input[name="drone"]:checked').value) { showErrorMessage('option'); return; } if (!$(".post-rating-feedback-note textarea") || !$(".post-rating-feedback-note textarea").value) { showErrorMessage('note'); return; } var selectedOption = $('input[name="drone"]:checked').value; var feedbackNote = $(".post-rating-feedback-note textarea").value; requestPayload.rating_feedback_type = selectedOption; requestPayload.rating_feedback = feedbackNote; } pureJSAjaxPost(addratingAPI, requestPayload, onsaveRatingSuccess, onsaveRatingFail, function() {}, true); } function resetRatingAndFeedbackForm() { var activeStars = Array.from($all('.rating span.rating-star.active')); for (var i=0; i < activeStars.length; i++) { activeStars[i].classList.remove("active"); } if ($('input[name="drone"]:checked')) { $('input[name="drone"]:checked').checked = false; } var userNote = document.querySelector(".post-rating-feedback-note textarea"); userNote.value = ''; modalPopup.close(); } function onsaveRatingSuccess() { modalPopup.close(); savePostIdInUserRatedPostsCookie(); $("#post-rating-layout").classList.add("hidden"); $("#post-rating-message").classList.remove("hidden"); window.setInterval(function showMessage() { $("#post-rating-widget").classList.add("hidden"); }, 3000); } function onsaveRatingFail() { console.error('Saving post rating failed!'); modalPopup.close(); } function savePostIdInUserRatedPostsCookie() { userRatedPostIds.push(1213989); var expiryTime = new Date(); expiryTime.setMonth(expiryTime.getMonth() + 12); // Expiry after 1 year setCookie("user_rated_post_ids", JSON.stringify(userRatedPostIds), expiryTime); } function isPostRatedByUser() { var userRatedPostIds = getCookie('user_rated_post_ids'); if (userRatedPostIds) { try { userRatedPostIds = JSON.parse(userRatedPostIds); } catch (err) { console.error(err); return false; } } else { return false; } if(userRatedPostIds.indexOf(1213989) >= 0) { return true; } else { return false; } } function getRatingCountByPostId(postId) { return new Promise(function(resolve, reject) { pureJSAjaxGet( getRatingCountBaseURL + postId + '/rating/count', function(data) { try { data = JSON.parse(data); if (data.meta_value) { resolve(data.meta_value); } reject("Failed to fetch rating count for the post:" + postId); } catch (err) { reject("Failed to fetch rating count for the post:" + postId); } }, function(err) { reject("Failed to fetch rating count for the post:" + postId); }, true); }); } function showErrorMessage(messageType) { var messageContainerId = '#' + messageType + '-error'; $(messageContainerId).classList.remove('hidden'); window.setInterval(function () { $(messageContainerId).classList.add("hidden"); }, 5000); } (function() { var callFired = false; function lazyLoadPostRating() { if (callFired) return; callFired = true; if (!isPostRatedByUser()) { getRatingCountByPostId(1213989) .then(function(ratingCount) { if (ratingCount < 10) { $("#post-rating-widget").classList.remove("hidden"); } }) .catch(function(err){ console.error(err); }); } } document.addEventListener("scroll", lazyLoadPostRating, { passive: true, once: true }); document.addEventListener("mousemove", lazyLoadPostRating, { passive: true, once: true }); document.addEventListener("touchmove", lazyLoadPostRating, { passive: true, once: true }); })();ncG1vNJzZmivp6x7tLzOq6uso5WasaJ6wqikaKaWoXyvsstmnZqmo2K%2Fpq3CrWStp12WrrO7zWapqJyXmr%2B0eceinqFln6N6sbHRnKacnaQ%3D